Search research articles
Contact Us
Filters
Showing results (61-70 of 99) with videos related to
Page
of 10
Sort By:
The Journal of Urology
|
November 1, 1989
Urothelial injury from ethylenediaminetetraacetic acid used as an irrigant in the urinary tract
M H Kane, J S Rodman, B Horten, et al.
The Biochemical Journal
|
January 29, 2014
Phosphatidylserine and FVa regulate FXa structure
Kinshuk Raj Srivasatava, Rinku Majumder, William H Kane, et al.
The Journal of Clinical Investigation
|
December 1, 1992
Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity
T L Ortel, M A Quinn-Allen, L A Charles, et al.
Thrombosis Research
|
May 3, 2008
Location of the multimerin 1 binding site in coagulation factor V: an update
Samira B Jeimy, Mary Ann Quinn-Allen, Nola Fuller, et al.
Biochimica Et Biophysica Acta
|
April 16, 1993
Protein kinase C isotypes and signal-transduction in human neutrophils: selective substrate specificity of calcium-dependent beta-PKC and novel calcium-independent nPKC
S Majumdar, L H Kane, M W Rossi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 24, 1999
Insulinotropic effect of new glibenclamide isosteres
R Ouedraogo, Q A Nguyen, M H Kane, et al.
Blood
|
August 15, 1993
Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria
T Wiedmer, S E Hall, T L Ortel, et al.
Clinical Chemistry
|
October 1, 1994
Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2
C S Greenberg, M J Hursting, B G Macik, et al.
The Journal of Biological Chemistry
|
June 3, 1994
Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimeras
T L Ortel, M A Quinn-Allen, F G Keller, et al.
Blood
|
June 15, 1996
An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect
C P Hayward, G E Rivard, W H Kane, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 99) with videos related to
Sort By:
Page
of 10
The Journal of Urology
|
November 1, 1989
Urothelial injury from ethylenediaminetetraacetic acid used as an irrigant in the urinary tract
M H Kane, J S Rodman, B Horten, et al.
The Biochemical Journal
|
January 29, 2014
Phosphatidylserine and FVa regulate FXa structure
Kinshuk Raj Srivasatava, Rinku Majumder, William H Kane, et al.
The Journal of Clinical Investigation
|
December 1, 1992
Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity
T L Ortel, M A Quinn-Allen, L A Charles, et al.
Thrombosis Research
|
May 3, 2008
Location of the multimerin 1 binding site in coagulation factor V: an update
Samira B Jeimy, Mary Ann Quinn-Allen, Nola Fuller, et al.
Biochimica Et Biophysica Acta
|
April 16, 1993
Protein kinase C isotypes and signal-transduction in human neutrophils: selective substrate specificity of calcium-dependent beta-PKC and novel calcium-independent nPKC
S Majumdar, L H Kane, M W Rossi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 24, 1999
Insulinotropic effect of new glibenclamide isosteres
R Ouedraogo, Q A Nguyen, M H Kane, et al.
Blood
|
August 15, 1993
Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria
T Wiedmer, S E Hall, T L Ortel, et al.
Clinical Chemistry
|
October 1, 1994
Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2
C S Greenberg, M J Hursting, B G Macik, et al.
The Journal of Biological Chemistry
|
June 3, 1994
Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimeras
T L Ortel, M A Quinn-Allen, F G Keller, et al.
Blood
|
June 15, 1996
An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect
C P Hayward, G E Rivard, W H Kane, et al.
Page
of 10